Copley-Merriman C, Yang X, Juniper M, Amin S, Yoo HK, Sen SS. Natural history and disease burden of neurofibromatosis type 1 with plexiform neurofibromas: a systematic review. Adolesc Health Med Ther. 2021 May 19;12:55-66. doi: 10.2147/AHMT.S303456
Copley-Merriman C, Yang X, Juniper M, Amin S, Yoo HK, Sen S. Impact of neurofibromatosis type 1 and plexiform neurofibromas on patient-reported health-related quality of life. Poster presented at the 2020 ISPOR Virtual Conference; May 2020. [abstract] Value Health. 2020 May 1; 23(Suppl 1):S344. doi: 10.1016/j.jval.2020.04.371
Le TK, Roskell NS, Mladsi DM, Mitra D, Shannon PR, Wilson AG, Juniper MD. Database analysis to estimate medical and pharmacotherapy resource utilization and costs of fibromyalgia prior to and following diagnosis in the United Kingdom primary care setting. Poster presented at the 25th Annual Meeting of the American Academy of Pain Medicine; January 2009. Hawaiian Village, Honolulu, HI.
Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson A, Garcia Cebrian A, Le KT. Pharmacological management of fibromyalgia in UK primary care. Poster presented at the19th Annual Clinical Meeting of the American Academy of Pain Management; September 2008. Nashville, TN.
Mladsi DM, Juniper MD, Roskell NS, Mitra D, Shannon PR, Wilson AG. The pharmacological management of fibromyalgia syndrome in the UK primary care setting. Presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.
Juniper MD, McCrink L, Mladsi DM, Le TK. The burden of fibromyalgia in France, Germany, Italy, Spain, and the UK: a literature-based review. Poster presented at the Annual Congress of the European League Against Rheumatism; June 2008. Paris, France.